414 related articles for article (PubMed ID: 35121998)
1. The current landscape of immunotherapy for pediatric brain tumors.
Hwang EI; Sayour EJ; Flores CT; Grant G; Wechsler-Reya R; Hoang-Minh LB; Kieran MW; Salcido J; Prins RM; Figg JW; Platten M; Candelario KM; Hale PG; Blatt JE; Governale LS; Okada H; Mitchell DA; Pollack IF
Nat Cancer; 2022 Jan; 3(1):11-24. PubMed ID: 35121998
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward.
Mishra DK; Popovski D; Morris SM; Bondoc A; Senthil Kumar S; Girard EJ; Rutka J; Fouladi M; Huang A; Olson JM; Drissi R
Neuro Oncol; 2024 Feb; 26(2):226-235. PubMed ID: 37713135
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity.
Finch EA; Duke E; Hwang EI; Packer RJ
Pediatr Neurol; 2020 Jun; 107():7-15. PubMed ID: 32113728
[TBL] [Abstract][Full Text] [Related]
5. Non-cellular immunotherapies in pediatric central nervous system tumors.
Rumler S
Front Immunol; 2023; 14():1242911. PubMed ID: 37885882
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy approaches for rare pediatric solid tumors: advances and future directions.
Fierro Pineda JC; Wedekind MF; Glod JW
Curr Opin Pediatr; 2023 Feb; 35(1):63-74. PubMed ID: 36420774
[TBL] [Abstract][Full Text] [Related]
7. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
Foster JB; Alonso MM; Sayour E; Davidson TB; Persson ML; Dun MD; Kline C; Mueller S; Vitanza NA; van der Lugt J
Neoplasia; 2023 Aug; 42():100909. PubMed ID: 37244226
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunotherapy for pediatric solid tumors.
Hegde M; Moll AJ; Byrd TT; Louis CU; Ahmed N
Cytotherapy; 2015 Jan; 17(1):3-17. PubMed ID: 25082406
[TBL] [Abstract][Full Text] [Related]
9. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
10. Immune Therapy for Central Nervous System Metastasis.
McAvoy MB; Choi BD; Jones PS
Neurosurg Clin N Am; 2020 Oct; 31(4):627-639. PubMed ID: 32921357
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies.
Casey DL; Cheung NV
Cancer Immunol Res; 2020 Feb; 8(2):161-166. PubMed ID: 32015013
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for pediatric brain tumors: past and present.
Foster JB; Madsen PJ; Hegde M; Ahmed N; Cole KA; Maris JM; Resnick AC; Storm PB; Waanders AJ
Neuro Oncol; 2019 Oct; 21(10):1226-1238. PubMed ID: 31504801
[TBL] [Abstract][Full Text] [Related]
13. Update on new treatments and developments in childhood brain tumors.
Partap S; Fisher PG
Curr Opin Pediatr; 2007 Dec; 19(6):670-4. PubMed ID: 18025934
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in cellular immunotherapy for brain/CNS tumors.
Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
[TBL] [Abstract][Full Text] [Related]
15. Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK
Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285
[TBL] [Abstract][Full Text] [Related]
16. A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies.
Rozowsky JS; Meesters-Ensing JI; Lammers JAS; Belle ML; Nierkens S; Kranendonk MEG; Kester LA; Calkoen FG; van der Lugt J
Front Immunol; 2022; 13():864423. PubMed ID: 35464481
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for brain tumors: understanding early successes and limitations.
Lieberman NAP; Vitanza NA; Crane CA
Expert Rev Neurother; 2018 Mar; 18(3):251-259. PubMed ID: 29322843
[TBL] [Abstract][Full Text] [Related]
18. The future of cancer immunotherapy for brain tumors: a collaborative workshop.
Brown CE; Bucktrout S; Butterfield LH; Futer O; Galanis E; Hormigo A; Lim M; Okada H; Prins R; Marr SS; Tanner K
J Transl Med; 2022 May; 20(1):236. PubMed ID: 35606815
[TBL] [Abstract][Full Text] [Related]
19. Update on Pediatric Brain Tumors: the Molecular Era and Neuro-immunologic Beginnings.
Duke ES; Packer RJ
Curr Neurol Neurosci Rep; 2020 Jun; 20(8):30. PubMed ID: 32564169
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
Pollack IF; Okada H; Chambers WH
Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
